Skip to NavigationSkip to content

News

0
Janssen has announced that Symtuza has received approval from the FDA in the treatment of HIV-1, making it the first and only darunavir-based single...
0
The Anglo-Swedish drug giant AstraZeneca is set to increase its stockpile of drugs in both the United Kingdom and the European Union in preparation...
0
Following US pharma giant Pfizer’s clash with President Donald Trump after it was called out on Twitter for hiking the prices of 100 of its...
0
A study published by researchers at McLean Hospital in Belmont, Massachusetts has led to the development of a statistical algorithm that is able to...

Features

In pharma R&D, data is king, but consistent struggles with patient retention is undermining the integrity of clinical findings. Matt Fellows...